Get startedLog in
    Picture of Suzhou Ribo Life Science logo

    6938 — Suzhou Ribo Life Science News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Suzhou Ribo Life Science Signs Exclusive Worldwide Licensing Deal With Madrigal

    Picture of Suzhou Ribo Life Science logoSuzhou Ribo Life Science
    11/02/2026 10:09
    Feb 11 (Reuters) - Suzhou Ribo Life Science Co Ltd 6938.HK:

EXCLUSIVE WORLDWIDE LICENSING AGREEMENT WITH MADRIGAL FOR SEVERAL SIRNA ASSETS

TO RECEIVE $60 MILLION UPFRONT PAYMENT, UP TO $4.4 BILLION TOTAL

LICENSING DEAL FOR 6 PRE-CLINICAL SIRNA PROGRAMS FOR TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS

Further company coverage: 6938.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Suzhou Ribo Life Science

    See all news